Benzylimidazole

Benzylimidazole

SCHEMBL414

c1ccc(Cn2ccnc2)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 16/20 1.00
CYP11B2 P19099 13/20 1.00
CYP19A1 P11511 6/20 1.00
CYP1A2 P05177 1/20 1.00
POLB P06746 1/20 1.00
CYP3A4 P08684 1/20 1.00
CYP2D6 P10635 1/20 1.00
MAPT P10636 1/20 1.00
TBXAS1 P24557 1/20 1.00
QPCT Q16769 1/20 1.00
CYP4Z1 Q86W10 1/20 1.00
QPCTL Q9NXS2 1/20 1.00
CYP17A1 P05093 1/20 0.79
CYP2A6 P11509 1/20 0.69
CYP2B6 P20813 1/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22063900 1.00 CYP11B1 (1.00) CYP11B1CYP11B2CYP19A1CYP1A2POLB
Benzylimidazole SCHEMBL31453527 0.98 CYP11B1 (0.96) CYP11B1CYP11B2CYP19A1CYP1A2POLB
Benzylimidazole SCHEMBL29239318 0.98 CYP11B1 (0.96) CYP11B1CYP11B2CYP19A1CYP1A2POLB
Benzylimidazole SCHEMBL16237308 0.98 CYP11B1 (0.96) CYP11B1CYP11B2CYP19A1CYP1A2POLB
Benzylimidazole SCHEMBL3786782 0.98 CYP11B1 (0.96) CYP11B1CYP11B2CYP19A1CYP1A2POLB
Benzylimidazole SCHEMBL411827 0.98 CYP11B1 (0.96) CYP11B1CYP11B2CYP19A1CYP1A2POLB
Benzylimidazole SCHEMBL27803894 0.94 CYP11B1 (0.89) CYP11B1CYP11B2CYP19A1CYP1A2POLB
Benzylimidazole SCHEMBL28764644 0.93 CYP11B1 (0.86) CYP11B1CYP11B2CYP19A1CYP1A2POLB
Benzylimidazole SCHEMBL27535101 0.93 CYP11B1 (0.86) CYP11B1CYP11B2CYP19A1CYP1A2POLB
Benzylimidazole SCHEMBL28970402 0.91 CYP11B1 (0.83) CYP11B1CYP11B2CYP19A1CYP1A2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 4205 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026047173-A1 PROCESS FOR PREPARING SUSTAINABLE JET FUELS OR DIESEL FUELS; AND PRECURSORS THEREOF Terra Mater BV (BE) 2026-03-05 WO claimed
US-20260015339-A1 CALIX[4]ARENES WITH HIGH ANTICANCER ACTIVITY UNIVERSITE GRENOBLE ALPES (FR) 2026-01-15 US claimed
EP-4667505-A1 USO DI ALMENO UN REAGENTE MONOMETRICO E/O OLIGOMERICO, COMPOSIZIONE RETICOLABILE IBRIDA EPOSSIDICA-POLIESTERE, COMPOSIZIONE RETICOLATA IBRIDA EPOSSIDICA-POLIESTERE, E RELATIVO METODO DI PRODUZIONE PANNELLO LAMINATO COMPOSITO PREPREG RETICOLABILE E RELATIVO METODO DI PRODUZIONE, METODO DI PRODUZIONE DI UN OGGETTO IN MATERIALE COMPOSITO RETICOLATO, METODI DI RICICLO DI UN ARTICOLO IN MATERIALE COMPOSITO RETICOLATO, E METODI DI PRODUZIONE DI UN ARTICOLO IN MATERIALE COMPOSITO RETICOLATO Crossfire S.r.l. (IT) 2025-12-24 EP claimed
EP-4655285-A1 CALIX[4]ARENES WITH HIGH ANTICANCER ACTIVITY Université Grenoble Alpes (FR) 2025-12-03 EP claimed
EP-4622945-A1 OLIGOMERISATION OF ALCOHOLS Terra Mater BV (BE) 2025-10-01 EP claimed
US-12398480-B2 Leveler compositions for use in copper deposition in manufacture of microelectronics MACDERMID ENTHONE INC. (US) 2025-08-26 US claimed
US-20250213647-A1 CHEMOKINE RECEPTORS AND ALPHA1 ADRENERGIC RECEPTORS/VASOPRESSIN RECEPTORS 1A HETEROMERS AS DRUG TARGETS FOR DISEASE UNIVERSITY OF SOUTH FLORIDA 2025-07-03 US claimed
WO-2025128828-A1 METHODS OF SOLVENT DISPLACEMENT FOR METAL-CONTAINING IONIC LIQUIDS CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2025-06-19 WO claimed
US-20250196021-A1 METHODS OF SOLVENT DISPLACEMENT FOR METAL-CONTAINING IONIC LIQUIDS CHEVRON PHILLIPS CHEMICAL COMPANY LP 2025-06-19 US claimed
CN-119972172-A Heterogeneous organic polymer catalyst, preparation method thereof and method for synthesizing aldehyde or lactone compound 武汉光化学技术研究院 2025-05-13 CN claimed
EP-0028410-B1 USE OF THROMBOXANE-SYNTHETASE INHIBITING COMPOUNDS IN THE TREATMENT OF OBESITY AND THE LOWERING OF INSULIN LEVELS F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1987-09-30 EP claimed
US-4662905-A REACTION PRODUCT OF COPPER SALT AND AN IMIDAZOLE, PYRAZOLE, TRIAZOLE, OR TETRAZOLE Itaru Todoriki, Director of Agency of Industrial Science and Technology (JP) 1987-05-05 US claimed
EP-0081679-B1 SUBSTITUTED BENZYLIMIDAZOLIUM SALTS AND MICROBICIDES CONTAINING THEM BASF Aktiengesellschaft (DE) 1986-01-29 EP claimed
US-4532268-A Imidazole agent for retarding the polymerization of aziridine compounds ESPE, FABRIK PHARMAZEUTISCHER PRAPARATE GMBH (DE) 1985-07-30 US claimed
US-4528308-A Epoxy resin curatives TEXACO INC. (US) 1985-07-09 US claimed
US-4500540-A DIETETICS HOFFMANN-LA ROCHE INC. (US) 1985-02-19 US claimed
US-4481211-A BACTERICIDES, FUNGICIDES, ALGICIDES BASF AKTIENGESELLSCHAFT (DE) 1984-11-06 US claimed
EP-0094329-A1 Tanning process for rendering leathers mycostatic, antimycosic and antifungicidal, and articles produced thereby Roux, Joel (FR) 1983-11-16 EP claimed
EP-0081679-A2 Substituted benzylimidazolium salts and microbicides containing them BASF Aktiengesellschaft (DE) 1983-06-22 EP claimed
EP-0028410-A1 Use of thromboxane-synthetase inhibiting compounds in the treatment of obesity and the lowering of insulin levels F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1981-05-13 EP claimed